About Us
Our Story
Team
Careers
News
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Select specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Confirm Password
Debate: Should VT Ablation Be the First Line Therapy Before ICD Implant in Patients Presenting with Monomorphic Ventricular Tachycardia?
By
10th Annual California Heart Rhythm Symposium
FEATURING
William Sauer
October 14, 2019
0 Comments
Login to view comments.
Click here to Login
Related Content
AUTOPLAY
ON
Boston Scientific
Biophysics of Ablation – Fundamentals and Myths
Fri, Jun 26, 2020
Faculty:
Boston Scientific
,
Roderick Tung
,
David Haines
ConvaTec
Risk Mitigation of Infection and Post-Operative Wound Complications …
Tue, Jul 28, 2020
Faculty:
Theofanie Mela
,
ConvaTec
,
Charles Love
,
Peter Belott
,
Bruce Wilkoff
Boston Scientific
Incorporating Local Impedance Into Your RF Ablation Practice
Mon, Sep 14, 2020
Faculty:
Roderick Tung
,
Christian Meyer
,
Boston Scientific
,
Suraj Kapa
Boston Scientific
S-ICD as a first-line therapy: Results from the PRAETORIAN & UNTOUCH…
Thu, Nov 5, 2020
Faculty:
Michael Gold
,
Ulrika Birgersdotter-Green
,
Boston Scientific
,
Reinoud Knops
11:37
ACC 2022 Conference Coverage
ACC 2022: An Embarrassment of Riches - Updated Guideline Recommendat…
Feat.
P. Heidenreich
51:47
Boston Scientific
Biophysics of Ablation – Fundamentals and Myths
Feat.
R. Tung,
D. Haines
21:19
10th Annual California Heart Rhythm Symposium
Surface ECG Recognition/Localization of Idiopathic VT
Feat.
S. Dixit
11:50
AHA 2022 Conference Coverage
AHA 2022: Risk Stratification and Treatment of Ventricular Arrhythmi…
Feat.
E. Kaufman
16:31
Courage and Innovation Symposium: Heart Failure & Heart Transplantation
Cardiac Sarcoidosis: Improving Diagnosis and Management
Feat.
B. Chung
32:19
Medtronic
iATP: A New Anti-Tachycardia Pacing Algorithm
Feat.
J. Cooper
15:09
ConvaTec
Management of the Infected Device Pocket Following CIED Surgery
Feat.
P. Belott
07:41
CVRx | Barostim
New Options for Heart Failure Patients with Narrow QRS
Feat.
J. Singh
15:28
Stanford Arrhythmia Symposium
Is Technology or Physiology the Challenge to Preventing Lethal Arrhy…
Feat.
D. Callans
18:06
Ulrika Birgersdotter-Green
Antitachycardia Pacing and VT Termination: Fact or Fancy?
45:22
Boston Scientific
Rate Adaptive Pacing Options for Patients with ICDs and CRTDs
Feat.
J. Cheung
03:01
BD
Patient Story: The use of Absorbable Hemostats to Control Bleeding i…
61:23
Boston Scientific
How to Manage HF Patient Workflows Using HeartLogic
Feat.
L. Steinkamp,
A. Sauer,
M. Galvao,
M. Emig,
R. McGee Taylor
04:22
CVRx | Barostim
Barostim Patient Identification
Feat.
R. Canby
15:15
ConvaTec
Prevention of CIED Infections: How Safe and (Cost)Effective Is the T…
Feat.
B. Wilkoff
06:09
CVRx | Barostim
The Need for New Device Therapies in HFrEF
Feat.
J. Singh
36:59
Medtronic
The Value of Reducing Potentially Unnecessary ICD Shocks: Do Benefit…
Feat.
M. Turakhia,
E. Schloss
18:51
ConvaTec
Perioperative and Intra-Operative Measures to Prevent Infection in C…
Feat.
T. Mela
12:34
CVRx | Barostim
The Need for Device Therapy in HFrEF
Feat.
W. Abraham
41:21
Medtronic
Is There a Need for Devices that Detect, Reduce, and Respond to AF?
Feat.
A. Al-Ahmad